started · updated
Researchers map how IDH-mutant glioma tumors evade treatment
A collaborative study involving Yale researchers, Massachusetts General Hospital, the Weizmann Institute of Science, and the University of Miami has mapped the progression of IDH-mutant glioma, an incurable brain tumor that frequently affects adults in their 30s and 40s.
Published in Nature, the research identifies two primary patterns in how these tumors evolve between initial diagnosis and recurrence. While some tumors remain relatively stable, others acquire new genetic alterations that shift the cancer into more aggressive, treatment-resistant states.
To reach these findings, the team analyzed molecular data from 35 patients using a combination of DNA sequencing, single-cell RNA sequencing, and single-cell chromatin accessibility profiling. This multi-layered approach allowed researchers to track genetic mutations and gene activity at the individual cell level, linking specific genetic events to the molecular changes that drive recurrence.
Entities
Massachusetts General Hospital · Roel Verhaak · University of Miami · Weizmann Institute of Science · Yale School of Medicine